Compounds > azoxymethane
Page last updated: 2024-08-23

azoxymethane and Diabetes Mellitus, Type 2

azoxymethane has been researched along with Diabetes Mellitus, Type 2 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Ibuka, T; Kato, J; Kubota, M; Mizutani, T; Ohnishi, M; Sakai, H; Shimizu, M; Shirakami, Y; Tanaka, T1
Ibuka, T; Kato, J; Kubota, M; Mizutani, T; Sakai, H; Shimizu, M; Shirakami, Y1
Imai, T; Ishigamori, R; Ito, K; Mutoh, M; Ohta, T; Takahashi, M1
Ramana, KV; Saxena, A; Shoeb, M; Srivastava, SK; Tammali, R1
Bronson, RT; Drori, S; Edelmann, W; Eng, C; Girnun, GD; Gonzalez, FJ; Kucherlapati, R; Mueller, E; Nambiar, P; Rosenberg, DW; Sarraf, P; Smith, WM; Spiegelman, BM1

Other Studies

5 other study(ies) available for azoxymethane and Diabetes Mellitus, Type 2

ArticleYear
Suppressive effects of the sodium‑glucose cotransporter 2 inhibitor tofogliflozin on colorectal tumorigenesis in diabetic and obese mice.
    Oncology reports, 2019, Volume: 42, Issue:6

    Topics: Animals; Azoxymethane; Benzhydryl Compounds; Blood Glucose; Carcinogenesis; Cell Proliferation; Colorectal Neoplasms; Diabetes Mellitus, Type 2; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Hypoglycemic Agents; Mice; Mice, Inbred NOD; Mice, Obese; Obesity; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Tumor Necrosis Factor-alpha

2019
Alpha-Glucosidase Inhibitor Voglibose Suppresses Azoxymethane-Induced Colonic Preneoplastic Lesions in Diabetic and Obese Mice.
    International journal of molecular sciences, 2020, Mar-23, Volume: 21, Issue:6

    Topics: Animals; Antioxidants; Azoxymethane; Biomarkers; Biopsy; Cell Proliferation; Colonic Neoplasms; Cytokines; Diabetes Mellitus, Type 2; Disease Models, Animal; Glycoside Hydrolase Inhibitors; Humans; Inflammation Mediators; Inositol; Intestinal Mucosa; Mice; NF-kappa B; Obesity; Oxidative Stress; Precancerous Conditions

2020
Ay allele promotes azoxymethane-induced colorectal carcinogenesis by macrophage migration in hyperlipidemic/diabetic KK mice.
    Cancer science, 2013, Volume: 104, Issue:7

    Topics: Alleles; Animals; Azoxymethane; beta Catenin; Carcinogenesis; Cell Movement; Cocarcinogenesis; Colorectal Neoplasms; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Hyperlipidemias; Inflammation; Insulin; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Inbred NOD; RNA, Messenger; Triglycerides

2013
Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.
    Cancer letters, 2014, Dec-01, Volume: 355, Issue:1

    Topics: Aldehyde Reductase; Animals; Anticarcinogenic Agents; Azoxymethane; Colon; Colonic Neoplasms; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Inhibitors; HT29 Cells; Humans; Imidazolidines; Inflammation Mediators; Intestinal Mucosa; Male; Mice, Inbred C57BL; Obesity; Oxidative Stress; Precancerous Conditions; Signal Transduction

2014
APC-dependent suppression of colon carcinogenesis by PPARgamma.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Oct-15, Volume: 99, Issue:21

    Topics: Animals; Azoxymethane; beta Catenin; Carcinogens; Colonic Neoplasms; Cytoskeletal Proteins; Diabetes Mellitus, Type 2; Gene Silencing; Genes, APC; Humans; Hypoglycemic Agents; Male; Mice; Mice, Knockout; Mutation; Receptors, Cytoplasmic and Nuclear; Thiazoles; Trans-Activators; Transcription Factors

2002